SCHEMBL2178624

SCHEMBL2178624

Cc1ccc(OC(c2ccc(S(=O)(=O)C3CC3)cc2)c2cc3c(Cl)cnnc3[nH]2)cc1

nearest known ligand 0.38

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
GCK P35557 12/20 0.38
SLC6A2 P23975 2/20 0.33
SLC6A4 P31645 2/20 0.33
SLC6A3 Q01959 2/20 0.33
KIT P10721 2/20 0.32
SMO Q99835 1/20 0.30
CNR1 P21554 1/20 0.30
SRC P12931 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2178905 0.67 GCK (0.38) GCKCNR1
SCHEMBL184731 0.65 GCK (0.50) GCK
SCHEMBL2180542 0.64 GCK (0.45) GCK
SCHEMBL5761130 0.63 GAA (0.52)
SCHEMBL2179681 0.63 GCK (0.48) GCK
SCHEMBL2177573 0.62 GCK (0.43) GCK
SCHEMBL11997743 0.61 GCK (0.83) GCK
SCHEMBL2177869 0.60 GCK (0.44) GCK
SCHEMBL11951572 0.59 MCOLN3 (0.51) GCKCNR1
SCHEMBL2180026 0.59 GCK (0.48) GCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011080755-A1 FUSED NITROGEN HETEROCYCLIC COMPOUNDS, PROCESS OF PREPARATION AND USES THEREOF ADVINUS THERAPEUTICS PRIVATE LIMITED (IN) 2011-07-07 WO claimed
WO-2011080755-A1 FUSED NITROGEN HETEROCYCLIC COMPOUNDS, PROCESS OF PREPARATION AND USES THEREOF ADVINUS THERAPEUTICS PRIVATE LIMITED (IN) 2011-07-07 WO disclosed